NDC 0264-7704

Isolyte S in Dextrose

Hydrous Dextrose, Sodium Chloride, Sodium Gluconate, Sodium Acetate Trihydrate, Potassium Chloride A

Isolyte S in Dextrose is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by B. Braun Medical Inc.. The primary component is Dextrose; Sodiu.

Product ID0264-7704_cb81fe4a-10a7-4e24-aa4f-b4315fcfe39b
NDC0264-7704
Product TypeHuman Prescription Drug
Proprietary NameIsolyte S in Dextrose
Generic NameHydrous Dextrose, Sodium Chloride, Sodium Gluconate, Sodium Acetate Trihydrate, Potassium Chloride A
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date1993-08-09
Marketing CategoryANDA / ANDA
Application NumberANDA019843
Labeler NameB. Braun Medical Inc.
Substance NameDEXTROSE; SODIU
Active Ingredient Strength5 g/100mL; g/100m
Pharm ClassesOsmotic Laxativ
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 0264-7704-00

12 CONTAINER in 1 CASE (0264-7704-00) > 1000 mL in 1 CONTAINER
Marketing Start Date1993-08-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0264-7704-00 [00264770400]

Isolyte S in Dextrose INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019843
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1993-08-09
Marketing End Date2014-05-30

Drug Details

Active Ingredients

IngredientStrength
DEXTROSE5 g/100mL

Pharmacological Class

  • Osmotic Laxative [EPC]
  • Increased Large Intestinal Motility [PE]
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
  • Osmotic Activity [MoA]
  • Potassium Compounds [CS]
  • Potassium Salt [EPC]
  • Osmotic Laxative [EPC]
  • Increased Large Intestinal Motility [PE]
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
  • Osmotic Activity [MoA]
  • Calculi Dissolution Agent [EPC]
  • Magnesium Ion Exchange Activity [MoA]
  • Osmotic Laxative [EPC]
  • Osmotic Activity [MoA]
  • Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
  • Increased Large Intestinal Motility [PE]
  • Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.